EPISODE · Nov 18, 2024 · 10 MIN
ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
from JACC This Week
In this episode, Dr. Valentin Fuster reviews an exploratory analysis from the 80s2 trial, which examined CSL 112's impact on ischemic events after acute myocardial infarction. While CSL 112 didn't significantly reduce cardiovascular death or stroke in the short term, the study found promising long-term benefits, suggesting that enhancing cholesterol efflux could be a valuable approach for reducing recurrent ischemic events in high-risk patients.
NOW PLAYING
ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m